Natixis Advisors, L.P. Stevanato Group S.P.A. Transaction History
Natixis Advisors, L.P.
- $46 Billion
- Q2 2024
A detailed history of Natixis Advisors, L.P. transactions in Stevanato Group S.P.A. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 42,674 shares of STVN stock, worth $853,480. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,674
Previous 33,528
27.28%
Holding current value
$853,480
Previous $1.08 Million
27.23%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding STVN
# of Institutions
136Shares Held
52.8MCall Options Held
1.5KPut Options Held
2.5K-
Conestoga Capital Advisors, LLC7.28MShares$146 Million2.03% of portfolio
-
Neuberger Berman Group LLC New York, NY4.55MShares$91 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.64MShares$72.7 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA2.58MShares$51.6 Million0.01% of portfolio
-
Jackson Square Partners, LLC San Francisco, CA2.22MShares$44.4 Million2.51% of portfolio
About Stevanato Group S.p.A.
- Ticker STVN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 264,700,000
- Market Cap $5.29B
- Description
- Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machine...